Co-Diagnostics CEO to present at 2015 SALSS in Stockholm, Sweden

Share Article

Co-Diagnostics CEO Dwight Egan will be a presenter at the 2015 Swedish-American Life Science Summit, taking place in August 19-21 in Stockholm, Sweden.

Co-Diagnostics CEO Dwight Egan will be a presenter at the 2015 Swedish-American Life Science Summit, taking place in August 19-21 in Stockholm, Sweden, the company confirmed today.

The SALSS began 11 years ago as a platform to increase international business and cooperation between the United States and Sweden, one of the most important life science industry centers in Europe. Through the years, it has increased globally and remains an invitation-only summit. Activities include high-level panel discussions, insights from keynote speakers and presentations from distinguished Life Science executives and investors throughout the world. Mr. Egan will be presenting along with many of these well-known individuals, with a focus this year on immunology, cancer and infectious disease.

Mr. Egan commented: “It will be an honor to spend this time getting to know so many prominent leaders in their respective fields, in both the world of biotechnology and in the investment community. I am confident in the technology developed by our founder, Dr. Brent Satterfield, and the progress we have made in preparing for its introduction on the global stage, and I look forward to being able to do so in such a prestigious venue.”

About Co-Diagnostics
Co-Diagnostics, Inc., a molecular diagnostics company, is a Utah corporation based in Sandy, Utah that develops, manufactures and markets fully-integrated DNA-based test systems. The company’s intellectual property is built on mathematical principles, creating proprietary algorithms in a unique, DNA-based diagnostics system that it deems to be superior both in cost and speed of development to other diagnostics systems, both in the US and abroad.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dwight Egan
Visit website